News | December 28, 2011

New Zealand Hospital Displays Success of Varian TrueBeam System

December 28, 2011 — Clinicians at one of New Zealand's leading hospitals have delivered more than 300 radiotherapy treatments using a newly installed TrueBeam device, from Varian Medical Systems, in the first month of its implementation. The system adds to Wellington Hospital's radiotherapy capabilities and enables fast, precise and efficient treatments.

The first patient in the country — and the southern hemisphere — to be treated with the device was an 18-year-old man with Hodgkin's disease. "He commented on the speed with which the treatment was delivered and was enthusiastic to be our first patient treated on TrueBeam," says Jennifer de Ridder, radiation therapist team leader at Wellington Hospital. "Many of our patients have commented on the speed of their treatments, which is a significant factor for those who are immobilized during treatment."

To manage treatment waiting times in New Zealand, the government recently introduced a target that all patients should commence radiotherapy within four weeks of a decision to treat. "We usually meet this target but need to be more efficient to continue meeting it in future," says Carole Johnson, clinical leader of radiation oncology. "So more advanced treatment techniques must be incorporated without making treatment slots longer and without impacting our ability to meet this waiting time target. TrueBeam helps us to achieve this."

The device at Wellington replaces a 14-year-old treatment machine and enables the hospital to expand its range of radiotherapy treatments; this includes intensity modulated radiotherapy, image-guided radiotherapy, RapidArc volumetric radiotherapy and, in the future, stereotactic radiotherapy.

The TrueBeam platform is a fully integrated radiotherapy system for image-guided radiotherapy and radiosurgery, designed to treat a moving target with speed and precision. It can be used to improve the treatment of lung, breast, prostate, head and neck cancer, among other types. It features a High Intensity Mode—one of six dose levels available to doctors—for customizing dose delivery based on a patient's specific tumor characteristics.

"In addition to improving workflow at the hospital, TrueBeam will enable us to introduce stereotactic body radiotherapy treatments for selected patients in 2012," says Lynne Greig, chief medical physicist. "It clearly positions us for the future while integrating easily with our existing suite of equipment."

Wellington Hospital treats 1,300 patients each year, providing external beam and high dose rate brachytherapy radiation treatments using Varian equipment and software. It is one of just eight radiotherapy departments in the country.

For more information: www.varian.com

 

Related Content

New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...